Oracle's $90 Billion Revenue Target Is Real. So Is the Negative Free Cash Flow Behind It.

Oracle just told its shareholders it expects at least $90 billion in revenue for the fiscal year that ends next May. It backed that number up with a quarter of cloud-infrastructure revenue growing 121% and a contract backlog of $664 billion, by far the largest in the company's history. A headline like that reads as pure good news. Behind it is a second, quieter number that explains why the stock still sits roughly half its high-water mark: Oracle's capital spending is now bigger than the cash its entire business produces.

That gap, not the growth rate, is the story the factor screen keeps pulling at.

The growth is real — and the $90 billion is credible

Let's attach a grade to the part that clearly works. Growth gets an A-plus here. In its fiscal first quarter, Oracle reported record total revenue of $19.3 billion, up 30% from a year earlier, with its cloud infrastructure business (the IaaS layer that rents out computing power and GPUs for AI workloads) growing 121% to $7.4 billion.

What makes the $90 billion target more than a marketing number is the backlog. Oracle's remaining performance obligations — signed cloud contracts not yet recognized as revenue — stood at $664 billion, up $209 billion year over year, after the quarter booked over $30 billion in new AI contracts. Management is raising non-GAAP EPS guidance to $8.10 even as revenue climbs toward $90 billion. Revisions are moving up, not sideways. On a GARP basis, this is the profile you want: high growth with improving estimates.

The trajectory behind the current year matters too. Oracle said it expects cloud infrastructure revenue to grow 77% this fiscal year to around $18 billion, and it has laid out a road to $32 billion, then $73 billion, then $114 billion in later years. The orders already sit in the backlog. Nothing about the demand side is the problem.

The catch is on the cash-flow statement

A-plus growth, A grade profitability on an accounting basis — Oracle's return on equity runs near 58% and its operating margin around 31%. So why is the stock down about 54% from its 52-week high even after a record quarter, and why did management fund the buildout partly by selling $20 billion of new stock?

Free cash flow is the metric the good headlines leave out, and it carries the explanation.

In the quarter, operating cash flow was a record $23 billion, up 184%. That sounds enormous. The problem is what the company spent back out: $28.5 billion in capital expenditures to stand up new data centers and GPUs. Spend more to build than the business generates in cash, and free cash flow turns negative — $5 billion in the quarter.

Stretch the lens to a full year and the picture sharpens. For fiscal 2026, Oracle generated $32 billion of operating cash flow but spent $55.7 billion on capital expenditures, a 162% jump. The result was negative free cash flow of $23.7 billion. The company has said it expects to raise about $40 billion in fiscal 2027 through a mix of debt and equity on top of the $20 billion at-the-market stock sale it already executed.

Here is the part worth slowing down for, because it is where the grade gets complicated for an ordinary investor. Revenue and earnings can grow impressively while the company still fails to convert that growth into cash — cash is what ultimately funds dividends, buybacks, and deleveraging, the things that decide whether a shareholder is actually paid for holding the stock. Right now Oracle's operations don't cover its building bill. It bridges the gap by borrowing and by issuing shares, and issuing shares chips away at each existing holder's slice of the company. Negative free cash flow plus dilution is how a stock can be down more than half while its revenue is up 30%.

What the factor stack says the stock is really pricing

Safety is the binding factor here, and it is a D against this balance sheet: roughly $218.7 billion in total debt and a debt-to-equity ratio near 3.0, with negative free cash flow on a TTM basis. Momentum is weak too — the stock trades below its 200-day average and has been in a drawdown even as the underlying reports improve.

Valuation, meanwhile, still commands a premium versus software peers: Oracle trades around 26 times trailing earnings, against about 21 for Salesforce and 21 for IBM. The market is paying a premium for growth it has yet to see convert to free cash flow. That is the mismatch. On a GARP screen you'd normally want valuation, growth, and profitability aligned; here growth and profitability are strong, but valuation is pricey and the cash-conversion leg is missing. AInvest's aggregate signal labels the stock a Buy, but an opaque aggregate rating doesn't change what the cash-flow statement shows.

So the honest read for a growth sleeve: Oracle is a high-growth, high-conviction bet on AI infrastructure whose economics are real and whose backlog makes the $90 billion target believable — held against the risk that the buildout keeps outspending cash generation and diluting shareholders along the way. The single number to watch is free cash flow, not revenue. If quarterly capex begins to moderate while the $664 billion backlog converts and free cash flow turns positive, the derating reverses its logic. Until then, the market is doing something rational: rewarding the growth in concept and discounting it in price.